When will a coronavirus vaccine be ready?
Around the world, politicians, drugmakers and regulators offer contradictory outlooks on when a COVID-19 vaccine will be ready. Much depends on what ‘ready’ means and for what group of people.…
All Strange Things About India and world
Around the world, politicians, drugmakers and regulators offer contradictory outlooks on when a COVID-19 vaccine will be ready. Much depends on what ‘ready’ means and for what group of people.…
NEW DELHI : BDR Pharmaceuticals, a Mumbai based drug company, on Wednesday announced the launched its antiviral drug Favipiravir for the treatment of coronavirus patients in India. The drug has…
WASHINGTON : Scientists have engineered a decoy protein which binds to the novel coronavirus and blocks infection in cultured cells, an advance that may lead to a therapeutic or preventive…
The US government has set a benchmark for COVID-19 vaccine pricing in a $2 billion deal announced on Wednesday with Pfizer Inc and German biotech BioNTech SE that will likely…
GENEVA : Researchers are making “good progress” in developing vaccines against COVID-19, with a handful in late-stage trials, but their first use cannot be expected until early 2021, a World…
Chris Whitty, UK Prime Minister Boris Johnson’s senior medical adviser, said there is only a slim chance of an effective coronavirus vaccine being available by Christmas, even as the University…
A Covid-19 vaccine developed with the Russian Defense Ministry completed Phase 2 trials, leading First Deputy Defense Minister Ruslan Tsalikov to say the first domestic inoculation is ready for use.…
GlaxoSmithKline Plc agreed to work with Germany’s CureVac on as many as five novel mRNA vaccines that will target infectious diseases as Covid-19 pushes companies and governments to focus on…
Seven months after the first patients were hospitalized in China battling an infection doctors had never seen before, the world has reached an unsettling crossroads. Countless hours of treatment and…
MELBOURNE : Scientists have discovered potential target points on the genome of the novel coronavirus, an advance which they claim may lead to the development of new treatments for the…